Eli Lilly
Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
Lilly plans price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value ...
MARCH 1, 2023
FDA Approves Lartruvo for Advanced Soft Tissue Sarcoma
Lartruvo is the first FDA-approved front-line therapy for soft tissue sarcoma in four decades.
OCTOBER 20, 2016
FDA Approves Taltz To Treat Psoriasis
Psoriasis affects about 7.5 million Americans, 20% of whom have moderate to severe plaque psoriasis.
MARCH 23, 2016
Load more